Russia's Enteromix cancer vaccine has reportedly demonstrated 100% efficacy and safety in initial human trials involving 48 volunteers, with patients experiencing significant tumor shrinkage and no serious side effects reported in the study.
Russia's Cancer Vaccine Shows 100% Efficacy in Clinical Trials